Actively Recruiting
Probiotics for Diaper Dermatitis
Led by University Maribor · Updated on 2025-11-24
42
Participants Needed
1
Research Sites
28 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years. The main question it aims to answer is: Is the probiotic OMNiBiOTiC® Panda effective in reducing the duration of diaper dermatitis in children under the age of two years? Researchers will compare the probiotic and placebo group to see if the duration of diaper dermatitis is significant among the two groups. Participants will: * receive 6 droplets daily of probiotic or placebo for 3 weeks and * observe and record improvement of diaper rash symptoms each day using a diary.
CONDITIONS
Official Title
Probiotics for Diaper Dermatitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Presence of diaper dermatitis
- Age less than two years
You will not qualify if you...
- Previous use of probiotics
- Age more than two years
- Having an acute bacterial infection
- Having a chronic disease
- Local use of antibiotics in the anogenital region
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Maribor, Faculty of Health Sciences
Maribor, Slovenia, 2000
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here